<code id='2C1B5F6D39'></code><style id='2C1B5F6D39'></style>
    • <acronym id='2C1B5F6D39'></acronym>
      <center id='2C1B5F6D39'><center id='2C1B5F6D39'><tfoot id='2C1B5F6D39'></tfoot></center><abbr id='2C1B5F6D39'><dir id='2C1B5F6D39'><tfoot id='2C1B5F6D39'></tfoot><noframes id='2C1B5F6D39'>

    • <optgroup id='2C1B5F6D39'><strike id='2C1B5F6D39'><sup id='2C1B5F6D39'></sup></strike><code id='2C1B5F6D39'></code></optgroup>
        1. <b id='2C1B5F6D39'><label id='2C1B5F6D39'><select id='2C1B5F6D39'><dt id='2C1B5F6D39'><span id='2C1B5F6D39'></span></dt></select></label></b><u id='2C1B5F6D39'></u>
          <i id='2C1B5F6D39'><strike id='2C1B5F6D39'><tt id='2C1B5F6D39'><pre id='2C1B5F6D39'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:41165
          ADAM FEUERSTEIN/STAT

          You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting.  Sign up here.

          CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

          advertisement

          Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          AstraZeneca, Daiichi breast cancer treatment succeeds in trial
          AstraZeneca, Daiichi breast cancer treatment succeeds in trial

          AlastairGrant/APLONDON—AstraZenecasaidFridayanexperimentaldrugtampeddowntheprogressionofacertaintype

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

          FILE-AmericanAirlinesplanesareparkedatPittsburghInternationalAirportonMarch31,2020,inImperial,Pa.Ame